title: Cancer. Quo vadis, specificity?
authors.affiliation: Department of Pathology, University of Chicago, Chicago, IL 60637, USA. hszz@midway.uchicago.edu
authors.forename: Hans
authors.initials: H
authors.lastname: Schreiber
authors.forename: Donald A
authors.initials: DA
authors.lastname: Rowley
mesh_terms: D000818:Animals; D017951:Antigen Presentation; D000951:Antigens, Neoplasm / Q000235:genetics / Q000276:immunology*; D001324:Autoantigens / Q000276:immunology*; D015551:Autoimmunity; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology*; D006657:Histones / Q000276:immunology*; D006801:Humans; D016219:Immunotherapy, Adoptive; D016246:Lymphocytes, Tumor-Infiltrating / Q000276:immunology*; D008297:Male; D051379:Mice; D009154:Mutation; D010446:Peptide Fragments / Q000276:immunology; D011471:Prostatic Neoplasms / Q000235:genetics / Q000276:immunology* / Q000628:therapy
chemical_list: D000951:Antigens, Neoplasm; D001324:Autoantigens; D006657:Histones; D010446:Peptide Fragments